✦ LIBER ✦

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

✍ Scribed by Christopher P Cannon; Sean P Curtis; Garret A FitzGerald; Henry Krum; Amarjot Kaur; James A Bolognese; Alise S Reicin; Claire Bombardier; Michael E Weinblatt; Désirée van der Heijde; Erland Erdmann; Loren Laine

Book ID: 117300173
Publisher: The Lancet
Year: 2006
Tongue: English
Weight: 214 KB
Volume: 368
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(06)69666-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of upper gastrointestinal saf

Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

✍ Loren Laine; Sean P Curtis; Byron Cryer; Amarjot Kaur; Christopher P Cannon 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 199 KB

Clinical trial design and patient demogr

Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) Study Program: Cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis

✍ Christopher P. Cannon; Sean P. Curtis; James A. Bolognese; Loren Laine 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Celecoxib versus omeprazole and diclofen

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial

✍ Francis KL Chan; Angel Lanas; James Scheiman; Manuela F Berger; Ha Nguyen; Jay L 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 220 KB

The long-term outcomes of rheumatoid art

The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis

✍ Frederick Wolfe; Samuel H. Zwillich 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 995 KB

Long-term anti-TNF therapy and the risk

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

✍ Atzeni, Fabiola; Sarzi-Puttini, Piercarlo; Botsios, Costantino; Carletto, Antoni 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 180 KB